Posted by Michael Wonder on 16 Apr 2021
AstraZeneca ChAdOx1-S COVID-19 vaccine
16 April 2021 - Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine.
The TGA's Vaccine Safety Investigation Group met late today and concluded that a recently reported case of thrombosis with thrombocytopenia is likely to be linked to vaccination.
VSIG reviewed a report about a 48-year-old woman who was vaccinated in New South Wales and admitted to hospital with an extensive thromboembolic event and thrombocytopenia four days after receiving the AstraZeneca COVID-19 Vaccine. Sadly, this person died in hospital and we extend our sincerest condolences to her family.
